Clinical features of anti-factor H autoantibody–associated hemolytic uremic syndrome
Atypical hemolytic uremic syndrome (aHUS) is a rare form of thrombotic microangiopathy
that associates, in 70% of cases, with genetic or acquired disorders leading to dysregulation …
that associates, in 70% of cases, with genetic or acquired disorders leading to dysregulation …
Atypical hemolytic uremic syndrome: what is it, how is it diagnosed, and how is it treated?
CM Nester, CP Thomas - Hematology 2010, the American …, 2012 - ashpublications.org
Atypical hemolytic uremic syndrome (aHUS) is a rare syndrome of hemolysis,
thrombocytopenia, and renal insufficiency. Genetic mutations in the alternate pathway of …
thrombocytopenia, and renal insufficiency. Genetic mutations in the alternate pathway of …
Atypical hemolytic uremic syndrome
V Afshar-Kharghan - Hematology 2014, the American Society …, 2016 - ashpublications.org
Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy (TMA) that
affects multiple organs and the kidneys in particular. aHUS can be sporadic or familial and is …
affects multiple organs and the kidneys in particular. aHUS can be sporadic or familial and is …
Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations
D Kavanagh, THJ Goodship - Hematology 2010, the American …, 2011 - ashpublications.org
Atypical hemolytic uremic syndrome (aHUS) is now well recognized to be a disease
characterized by excessive complement activation in the microvasculature. In both the …
characterized by excessive complement activation in the microvasculature. In both the …
Atypical hemolytic uremic syndrome: new challenges in the complement blockage era
AI Avila Bernabeu, T Cavero Escribano, M Cao Vilarino - Nephron, 2020 - karger.com
Atypical hemolytic uremic syndrome (aHUS) is a rare cause of thrombotic microangiopathy
(TMA), characterized by microangiopathic hemolytic anemia, consumptive …
(TMA), characterized by microangiopathic hemolytic anemia, consumptive …
[HTML][HTML] Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with …
Atypical hemolytic uremic syndrome (aHUS) is a rare, genetic, progressive, life-threatening
form of thrombotic microangiopathy (TMA) predominantly caused by dysregulation of the …
form of thrombotic microangiopathy (TMA) predominantly caused by dysregulation of the …
Atypical hemolytic‐uremic syndrome: an update on pathophysiology, diagnosis, and treatment
R Raina, V Krishnappa, T Blaha, T Kann… - Therapeutic …, 2019 - Wiley Online Library
Atypical hemolytic uremic syndrome (aHUS), a rare variant of thrombotic microangiopathy, is
characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal …
characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal …
[HTML][HTML] Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors
A Le Clech, N Simon-Tillaux, F Provôt, Y Delmas… - Kidney international, 2019 - Elsevier
Secondary hemolytic uremic syndrome (HUS) is a heterogeneous group of thrombotic
microangiopathies associated with various underlying conditions. Whether it belongs to the …
microangiopathies associated with various underlying conditions. Whether it belongs to the …
[PDF][PDF] Atypical hemolytic uremic syndrome (aHUS): making the diagnosis
J Laurence - Clin Adv Hematol Oncol, 2012 - hematologyandoncology.net
Atypical hemolytic uremic syndrome (aHUS) is a major thrombotic microangiopathy (TMA). A
TMA is recognized by the laboratory signs of microangiopathic hemolysis, as indicated by …
TMA is recognized by the laboratory signs of microangiopathic hemolysis, as indicated by …
Alternative complement pathway assessment in patients with atypical HUS
LT Roumenina, C Loirat, MA Dragon-Durey… - Journal of …, 2011 - Elsevier
The atypical Hemolytic Uremic Syndrome (aHUS) is a rare thrombotic microangiopathy
leading to end stage renal disease in approximately 60% of patients. Over the last decade, a …
leading to end stage renal disease in approximately 60% of patients. Over the last decade, a …